GE HealthCare unveils ultra-premium, high-performance gradient 1.5T MRI system

GE HealthCare unveiled SIGNA™ Sprint, an FDA 510(k) pending ultra-premium wide bore 1.5T high-performance gradient MRI system, at the International Society for Magnetic Resonance in Medicine (ISMRM) 2025. This innovative technology is designed to unlock advanced imaging possibilities in cardiology, oncology and other clinical and research areas.

The need for advanced diagnostics in cardiology and oncology continues to grow, with cardiovascular disease accounting for 32% of global deaths, and cancer accounting for nearly 10 million deaths per year. Meeting this demand with advanced MRI technologies has the potential to make a significant impact on cardiology and oncology patients.

With the goal of delivering higher gradient benefits previously attainable on only 3.0T systems, SIGNA Sprint is designed to offer high-performance scanning made simple at 1.5T, with exceptional diffusion imaging, a critical tool in oncology diagnosis and treatment planning. SIGNA Sprint is also designed to equip clinicians and researchers with the ability to expand the current 1.5T boundaries, aiming to enable fast clinical translation and pioneering research.

SIGNA Sprint, with a high-gradient performance of 65/200 per axis for fast imaging and exceptional image quality, is designed to deliver crystal-clear visualization of sub-millimetric structures and deep learning solutions to support diagnostics and treatment response monitoring in oncology patients. This new system supports clinicians’ shift to quantitative MRI and a deeper understanding of tissue characteristics, going beyond basic assessment of anatomy. The adoption of deep-learning reconstruction techniques for accelerated cardiac MRI aims to reduce the time and expertise needed to interpret scans and drive consistency and reliability.

SIGNA Sprint also is designed to optimize patient comfort, providing a 70cm wide bore space, free-breathing capabilities, and blanket-like AIR ™ Coils to improve the patient experience. This next-generation, high-performance platform is designed to benefit from built-in AI technologies – AIR™ Recon DL, Sonic DL™ and AIR x™ – which enable high-quality imaging even in the most demanding anatomies. SIGNA Sprint aims to support clinician goals of providing precision care through the entire care pathway, from the early diagnostic stage to treatment monitoring.